Global Poliomyelitis Vaccines Market Research Report 2026(Status and Outlook)
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Poliomyelitis Vaccines market size was estimated at USD 3283.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Poliomyelitis Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Poliomyelitis Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Poliomyelitis Vaccines market.
Global Poliomyelitis Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
IPV
OPV
Market Segmentation (by Application)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Poliomyelitis Vaccines Market
Overview of the regional outlook of the Poliomyelitis Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliomyelitis Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Poliomyelitis Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Poliomyelitis Vaccines market size was estimated at USD 3283.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Poliomyelitis Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Poliomyelitis Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Poliomyelitis Vaccines market.
Global Poliomyelitis Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
IPV
OPV
Market Segmentation (by Application)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Poliomyelitis Vaccines Market
Overview of the regional outlook of the Poliomyelitis Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliomyelitis Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Poliomyelitis Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Poliomyelitis Vaccines
1.2 Key Market Segments
1.2.1 Poliomyelitis Vaccines Segment by Type
1.2.2 Poliomyelitis Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOMYELITIS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliomyelitis Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Poliomyelitis Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOMYELITIS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Poliomyelitis Vaccines Product Life Cycle
3.3 Global Poliomyelitis Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Poliomyelitis Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliomyelitis Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Poliomyelitis Vaccines Market Competitive Situation and Trends
3.8.1 Poliomyelitis Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Poliomyelitis Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POLIOMYELITIS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Poliomyelitis Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOMYELITIS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Poliomyelitis Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Poliomyelitis Vaccines Market
5.7 ESG Ratings of Leading Companies
6 POLIOMYELITIS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Poliomyelitis Vaccines Market Size by Type (2020-2025)
6.4 Global Poliomyelitis Vaccines Price by Type (2020-2025)
7 POLIOMYELITIS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliomyelitis Vaccines Market Sales by Application (2020-2025)
7.3 Global Poliomyelitis Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
8 POLIOMYELITIS VACCINES MARKET SALES BY REGION
8.1 Global Poliomyelitis Vaccines Sales by Region
8.1.1 Global Poliomyelitis Vaccines Sales by Region
8.1.2 Global Poliomyelitis Vaccines Sales Market Share by Region
8.2 Global Poliomyelitis Vaccines Market Size by Region
8.2.1 Global Poliomyelitis Vaccines Market Size by Region
8.2.2 Global Poliomyelitis Vaccines Market Size by Region
8.3 North America
8.3.1 North America Poliomyelitis Vaccines Sales by Country
8.3.2 North America Poliomyelitis Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Poliomyelitis Vaccines Sales by Country
8.4.2 Europe Poliomyelitis Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Poliomyelitis Vaccines Sales by Region
8.5.2 Asia Pacific Poliomyelitis Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Poliomyelitis Vaccines Sales by Country
8.6.2 South America Poliomyelitis Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Poliomyelitis Vaccines Sales by Region
8.7.2 Middle East and Africa Poliomyelitis Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POLIOMYELITIS VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Poliomyelitis Vaccines by Region(2020-2025)
9.2 Global Poliomyelitis Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Poliomyelitis Vaccines Production
9.4.1 North America Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Poliomyelitis Vaccines Production
9.5.1 Europe Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Poliomyelitis Vaccines Production (2020-2025)
9.6.1 Japan Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Poliomyelitis Vaccines Production (2020-2025)
9.7.1 China Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.7.2 China Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Poliomyelitis Vaccines Product Overview
10.1.3 Sanofi Poliomyelitis Vaccines Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Poliomyelitis Vaccines Product Overview
10.2.3 GSK Poliomyelitis Vaccines Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Poliomyelitis Vaccines Product Overview
10.3.3 Bibcol Poliomyelitis Vaccines Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Poliomyelitis Vaccines Product Overview
10.4.3 Serum Institute Poliomyelitis Vaccines Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Poliomyelitis Vaccines Product Overview
10.5.3 Tiantan Biological Poliomyelitis Vaccines Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 IMBCA
10.6.1 IMBCA Basic Information
10.6.2 IMBCA Poliomyelitis Vaccines Product Overview
10.6.3 IMBCA Poliomyelitis Vaccines Product Market Performance
10.6.4 IMBCA Business Overview
10.6.5 IMBCA Recent Developments
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Basic Information
10.7.2 Panacea Biotec Ltd Poliomyelitis Vaccines Product Overview
10.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Product Market Performance
10.7.4 Panacea Biotec Ltd Business Overview
10.7.5 Panacea Biotec Ltd Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Poliomyelitis Vaccines Product Overview
10.8.3 Bio-Med Poliomyelitis Vaccines Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Basic Information
10.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Overview
10.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Market Performance
10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 POLIOMYELITIS VACCINES MARKET FORECAST BY REGION
11.1 Global Poliomyelitis Vaccines Market Size Forecast
11.2 Global Poliomyelitis Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Poliomyelitis Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Poliomyelitis Vaccines Market Size Forecast by Region
11.2.4 South America Poliomyelitis Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Poliomyelitis Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Poliomyelitis Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Poliomyelitis Vaccines by Type (2026-2035)
12.1.2 Global Poliomyelitis Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Poliomyelitis Vaccines by Type (2026-2035)
12.2 Global Poliomyelitis Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Poliomyelitis Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Poliomyelitis Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Poliomyelitis Vaccines
1.2 Key Market Segments
1.2.1 Poliomyelitis Vaccines Segment by Type
1.2.2 Poliomyelitis Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOMYELITIS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliomyelitis Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Poliomyelitis Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOMYELITIS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Poliomyelitis Vaccines Product Life Cycle
3.3 Global Poliomyelitis Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Poliomyelitis Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliomyelitis Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Poliomyelitis Vaccines Market Competitive Situation and Trends
3.8.1 Poliomyelitis Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Poliomyelitis Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POLIOMYELITIS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Poliomyelitis Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOMYELITIS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Poliomyelitis Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Poliomyelitis Vaccines Market
5.7 ESG Ratings of Leading Companies
6 POLIOMYELITIS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Poliomyelitis Vaccines Market Size by Type (2020-2025)
6.4 Global Poliomyelitis Vaccines Price by Type (2020-2025)
7 POLIOMYELITIS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliomyelitis Vaccines Market Sales by Application (2020-2025)
7.3 Global Poliomyelitis Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
8 POLIOMYELITIS VACCINES MARKET SALES BY REGION
8.1 Global Poliomyelitis Vaccines Sales by Region
8.1.1 Global Poliomyelitis Vaccines Sales by Region
8.1.2 Global Poliomyelitis Vaccines Sales Market Share by Region
8.2 Global Poliomyelitis Vaccines Market Size by Region
8.2.1 Global Poliomyelitis Vaccines Market Size by Region
8.2.2 Global Poliomyelitis Vaccines Market Size by Region
8.3 North America
8.3.1 North America Poliomyelitis Vaccines Sales by Country
8.3.2 North America Poliomyelitis Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Poliomyelitis Vaccines Sales by Country
8.4.2 Europe Poliomyelitis Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Poliomyelitis Vaccines Sales by Region
8.5.2 Asia Pacific Poliomyelitis Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Poliomyelitis Vaccines Sales by Country
8.6.2 South America Poliomyelitis Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Poliomyelitis Vaccines Sales by Region
8.7.2 Middle East and Africa Poliomyelitis Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POLIOMYELITIS VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Poliomyelitis Vaccines by Region(2020-2025)
9.2 Global Poliomyelitis Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Poliomyelitis Vaccines Production
9.4.1 North America Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Poliomyelitis Vaccines Production
9.5.1 Europe Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Poliomyelitis Vaccines Production (2020-2025)
9.6.1 Japan Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Poliomyelitis Vaccines Production (2020-2025)
9.7.1 China Poliomyelitis Vaccines Production Growth Rate (2020-2025)
9.7.2 China Poliomyelitis Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Poliomyelitis Vaccines Product Overview
10.1.3 Sanofi Poliomyelitis Vaccines Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Poliomyelitis Vaccines Product Overview
10.2.3 GSK Poliomyelitis Vaccines Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Poliomyelitis Vaccines Product Overview
10.3.3 Bibcol Poliomyelitis Vaccines Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Poliomyelitis Vaccines Product Overview
10.4.3 Serum Institute Poliomyelitis Vaccines Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Poliomyelitis Vaccines Product Overview
10.5.3 Tiantan Biological Poliomyelitis Vaccines Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 IMBCA
10.6.1 IMBCA Basic Information
10.6.2 IMBCA Poliomyelitis Vaccines Product Overview
10.6.3 IMBCA Poliomyelitis Vaccines Product Market Performance
10.6.4 IMBCA Business Overview
10.6.5 IMBCA Recent Developments
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Basic Information
10.7.2 Panacea Biotec Ltd Poliomyelitis Vaccines Product Overview
10.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Product Market Performance
10.7.4 Panacea Biotec Ltd Business Overview
10.7.5 Panacea Biotec Ltd Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Poliomyelitis Vaccines Product Overview
10.8.3 Bio-Med Poliomyelitis Vaccines Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Basic Information
10.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Overview
10.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Market Performance
10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 POLIOMYELITIS VACCINES MARKET FORECAST BY REGION
11.1 Global Poliomyelitis Vaccines Market Size Forecast
11.2 Global Poliomyelitis Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Poliomyelitis Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Poliomyelitis Vaccines Market Size Forecast by Region
11.2.4 South America Poliomyelitis Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Poliomyelitis Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Poliomyelitis Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Poliomyelitis Vaccines by Type (2026-2035)
12.1.2 Global Poliomyelitis Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Poliomyelitis Vaccines by Type (2026-2035)
12.2 Global Poliomyelitis Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Poliomyelitis Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Poliomyelitis Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliomyelitis Vaccines Market Size by Type (M USD)
Table 4. Global Poliomyelitis Vaccines Market Size by Application
Table 5. Poliomyelitis Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Poliomyelitis Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliomyelitis Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliomyelitis Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2025)
Table 11. Global Market Poliomyelitis Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Poliomyelitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliomyelitis Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Poliomyelitis Vaccines Sales by Type (K MT)
Table 27. Global Poliomyelitis Vaccines Market Size by Type (M USD)
Table 28. Global Poliomyelitis Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Poliomyelitis Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Poliomyelitis Vaccines Market Share by Type (2020-2025)
Table 32. Global Poliomyelitis Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Poliomyelitis Vaccines Sales (K MT) by Application
Table 34. Global Poliomyelitis Vaccines Market Size by Application
Table 35. Global Poliomyelitis Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Poliomyelitis Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Poliomyelitis Vaccines Market Share by Application (2020-2025)
Table 39. Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Poliomyelitis Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Poliomyelitis Vaccines Market Size by Region (2020-2025)
Table 44. North America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Poliomyelitis Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Poliomyelitis Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Poliomyelitis Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Poliomyelitis Vaccines Product Overview
Table 64. Sanofi Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Poliomyelitis Vaccines Product Overview
Table 70. GSK Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Poliomyelitis Vaccines Product Overview
Table 76. Bibcol Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Poliomyelitis Vaccines Product Overview
Table 82. Serum Institute Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Poliomyelitis Vaccines Product Overview
Table 87. Tiantan Biological Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Basic Information
Table 91. IMBCA Poliomyelitis Vaccines Product Overview
Table 92. IMBCA Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. IMBCA Business Overview
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Ltd Basic Information
Table 96. Panacea Biotec Ltd Poliomyelitis Vaccines Product Overview
Table 97. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Panacea Biotec Ltd Business Overview
Table 99. Panacea Biotec Ltd Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Poliomyelitis Vaccines Product Overview
Table 102. Bio-Med Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Basic Information
Table 106. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Halfkin Bio-Pharmaceuticals Business Overview
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. Global Poliomyelitis Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Poliomyelitis Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Poliomyelitis Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Poliomyelitis Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Poliomyelitis Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Poliomyelitis Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Poliomyelitis Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Poliomyelitis Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Poliomyelitis Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliomyelitis Vaccines Market Size by Type (M USD)
Table 4. Global Poliomyelitis Vaccines Market Size by Application
Table 5. Poliomyelitis Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Poliomyelitis Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliomyelitis Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliomyelitis Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2025)
Table 11. Global Market Poliomyelitis Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Poliomyelitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliomyelitis Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Poliomyelitis Vaccines Sales by Type (K MT)
Table 27. Global Poliomyelitis Vaccines Market Size by Type (M USD)
Table 28. Global Poliomyelitis Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Poliomyelitis Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Poliomyelitis Vaccines Market Share by Type (2020-2025)
Table 32. Global Poliomyelitis Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Poliomyelitis Vaccines Sales (K MT) by Application
Table 34. Global Poliomyelitis Vaccines Market Size by Application
Table 35. Global Poliomyelitis Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Poliomyelitis Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Poliomyelitis Vaccines Market Share by Application (2020-2025)
Table 39. Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Poliomyelitis Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Poliomyelitis Vaccines Market Size by Region (2020-2025)
Table 44. North America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Poliomyelitis Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Poliomyelitis Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Poliomyelitis Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Poliomyelitis Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Poliomyelitis Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Poliomyelitis Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Poliomyelitis Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Poliomyelitis Vaccines Product Overview
Table 64. Sanofi Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Poliomyelitis Vaccines Product Overview
Table 70. GSK Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Poliomyelitis Vaccines Product Overview
Table 76. Bibcol Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Poliomyelitis Vaccines Product Overview
Table 82. Serum Institute Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Poliomyelitis Vaccines Product Overview
Table 87. Tiantan Biological Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Basic Information
Table 91. IMBCA Poliomyelitis Vaccines Product Overview
Table 92. IMBCA Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. IMBCA Business Overview
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Ltd Basic Information
Table 96. Panacea Biotec Ltd Poliomyelitis Vaccines Product Overview
Table 97. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Panacea Biotec Ltd Business Overview
Table 99. Panacea Biotec Ltd Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Poliomyelitis Vaccines Product Overview
Table 102. Bio-Med Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Basic Information
Table 106. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Halfkin Bio-Pharmaceuticals Business Overview
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. Global Poliomyelitis Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Poliomyelitis Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Poliomyelitis Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Poliomyelitis Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Poliomyelitis Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Poliomyelitis Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Poliomyelitis Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Poliomyelitis Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Poliomyelitis Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Poliomyelitis Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Poliomyelitis Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Poliomyelitis Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliomyelitis Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Poliomyelitis Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Poliomyelitis Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliomyelitis Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliomyelitis Vaccines Product Life Cycle
Figure 13. Poliomyelitis Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Poliomyelitis Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Poliomyelitis Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Poliomyelitis Vaccines
Figure 19. Global Poliomyelitis Vaccines Market PEST Analysis
Figure 20. Global Poliomyelitis Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Poliomyelitis Vaccines Market Share by Type
Figure 27. Sales Market Share of Poliomyelitis Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Poliomyelitis Vaccines by Type in 2025
Figure 29. Market Share of Poliomyelitis Vaccines by Type (2020-2025)
Figure 30. Market Share of Poliomyelitis Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Poliomyelitis Vaccines Market Share by Application
Figure 33. Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Poliomyelitis Vaccines Sales Market Share by Application in 2025
Figure 35. Global Poliomyelitis Vaccines Market Share by Application (2020-2025)
Figure 36. Global Poliomyelitis Vaccines Market Share by Application in 2025
Figure 37. Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Poliomyelitis Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Poliomyelitis Vaccines Market Size by Region (2020-2025)
Figure 40. North America Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 43. North America Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Poliomyelitis Vaccines Market Size by Country in 2024
Figure 45. U.S. Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Poliomyelitis Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Poliomyelitis Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Poliomyelitis Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Poliomyelitis Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Poliomyelitis Vaccines Market Size by Country in 2024
Figure 55. Germany Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Poliomyelitis Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Poliomyelitis Vaccines Market Size by Region in 2024
Figure 68. China Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 80. South America Poliomyelitis Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Poliomyelitis Vaccines Market Size by Country in 2024
Figure 82. Brazil Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Poliomyelitis Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Poliomyelitis Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Poliomyelitis Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Poliomyelitis Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Poliomyelitis Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Poliomyelitis Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Poliomyelitis Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Poliomyelitis Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Poliomyelitis Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Poliomyelitis Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Poliomyelitis Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliomyelitis Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Poliomyelitis Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Poliomyelitis Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliomyelitis Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliomyelitis Vaccines Product Life Cycle
Figure 13. Poliomyelitis Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Poliomyelitis Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Poliomyelitis Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Poliomyelitis Vaccines
Figure 19. Global Poliomyelitis Vaccines Market PEST Analysis
Figure 20. Global Poliomyelitis Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Poliomyelitis Vaccines Market Share by Type
Figure 27. Sales Market Share of Poliomyelitis Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Poliomyelitis Vaccines by Type in 2025
Figure 29. Market Share of Poliomyelitis Vaccines by Type (2020-2025)
Figure 30. Market Share of Poliomyelitis Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Poliomyelitis Vaccines Market Share by Application
Figure 33. Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Poliomyelitis Vaccines Sales Market Share by Application in 2025
Figure 35. Global Poliomyelitis Vaccines Market Share by Application (2020-2025)
Figure 36. Global Poliomyelitis Vaccines Market Share by Application in 2025
Figure 37. Global Poliomyelitis Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Poliomyelitis Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Poliomyelitis Vaccines Market Size by Region (2020-2025)
Figure 40. North America Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 43. North America Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Poliomyelitis Vaccines Market Size by Country in 2024
Figure 45. U.S. Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Poliomyelitis Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Poliomyelitis Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Poliomyelitis Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Poliomyelitis Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Poliomyelitis Vaccines Market Size by Country in 2024
Figure 55. Germany Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Poliomyelitis Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Poliomyelitis Vaccines Market Size by Region in 2024
Figure 68. China Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Poliomyelitis Vaccines Sales Market Share by Country in 2024
Figure 80. South America Poliomyelitis Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Poliomyelitis Vaccines Market Size by Country in 2024
Figure 82. Brazil Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Poliomyelitis Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Poliomyelitis Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Poliomyelitis Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Poliomyelitis Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Poliomyelitis Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Poliomyelitis Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Poliomyelitis Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Poliomyelitis Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Poliomyelitis Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Poliomyelitis Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Poliomyelitis Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Poliomyelitis Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Poliomyelitis Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Poliomyelitis Vaccines Market Share Forecast by Application (2026-2035)
